Gurwitz and colleagues propose that consortia dedicated to archiving and analysing data on associations between genotypes and drug-response phenotypes could allow the potential of personalized medicine to be realized, and discuss the associated practical and ethical issues that need to be addressed.
- David Gurwitz
- Jeantine E. Lunshof
- Russ B. Altman